Praziquantel injection bulk supplier for pharma manufacturers

Praziquantel Injection 56.8 mg/ml Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 56.8 mg/ml

Reference Brands: Droncit & Generic formulations for this form in EU & US

Praziquantel injection works by disrupting the parasite’s tegument (body surface), causing paralysis and death of trematodes and cestodes. It effectively treats schistosomiasis and tapeworm infections in animals and humans. Benefits include rapid parasite elimination, reduced disease transmission, and improved health outcomes, especially in endemic regions.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Praziquantel injection is authorized in the EU and US, supported by dossiers demonstrating safety, efficacy, and manufacturing quality according to GMP standards. In the US, FDA approval requires extensive clinical data and safety evaluation, while in the EU, CE marking certifies conformity with veterinary medicinal product regulations. These products undergo validation, stability testing, and quality audits, with detailed documentation including safety profiles, clinical trial data, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring regulatory compliance guarantees access to safe, effective praziquantel formulations for treating parasitic infections in animals worldwide.

Praziquantel Injection — third party manufacturing & bulk supply

Praziquantel Injection 56.8 mg/ml is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Praziquantel Injection is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Praziquantel Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Praziquantel Injection →

Back to Listing

Frequently Asked Questions

Praziquantel injection is listed as Injection in 56.8 mg/ml. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Praziquantel injection is referenced against Droncit & Generic formulations for this form in EU & US. Reference brands are shown for identification only and remain the property of their respective trademark owners.